Associating conditional cash transfer to universal access to treatment could be the solution to the HCV epidemic among drug users (DUs)

Table 5 Characteristics related to drug use

	Observed number	Percent	95% CI
History of injection
NSS+	114	34.9	29.9–40.2
NSS−	89	27.2	22.7–32.3
None	125	38.2	32.9–43.5
Treatment for drug use
Never	80	24.5	19.5–28.7
Current	202	61.8	56.5–67.1
Given up	45	13.9	10.1–17.5
Drug treatment center	59	28.7	23.32–33.08
Low threshold services	26	12.9	9.27–16.53
Bus	23	11.4	7.96–14.84
GPs	141	69.8	64.82–74.78
Current opiate substitution therapy
Methadone	85	26	21.3–31.1
Buprenorphine	65	19.9	15.7–24.6
Morphine sulfate	15	8.6	2.6–7.5
Fears
Prison	161	49.2	43.9–54.6
Not stopping drug use	146	44.6	39.4–50.0
Contamination	143	43.7	38.5–49.2
Staying alone	138	42.2	37.0–47.6
Losing one’s friends	117	35.8	30.8–41.1
Overdose	91	27.8	23.3–32.9
Not paying one’s debts	74	22.6	18.4–27.5
Stopping drug use	69	21.1	17.0–25.9
Losing custody of children	44	13.5	15.6–24.2
Losing contact with friends	34	10.4	7.54–14.2
Losing one’s job	32	9.8	7.0–13.5
Sources of health information
GP	180	55	49.6–60.4
Friends	121	37	32.0–42.4
SDU	90	27.5	23.0–32.6
Internet (computer)	89	27.2	22.7–32.3
Television	86	26.3	21.8–31.3
Booklet	85	26	21.5–31.0
Stand	50	15.3	11.8–19.6
Family	46	14.1	10.7–18.3
Press (free)	42	12.8	9.6–16.9
Internet (smartphone)	26	8	5.5–11.4
Social networks	25	7.6	5.2–11.0
Press (paid for)	23	7	1.7–10.3
HCV screening
Adequate	241	73.7	68.7–78.2
Inadequate	26	7.95	5.5–11.4
Absent	60	18.3	15.5–22.9
Positive	61	22.8^a	18.2–28.3
Negative	206	77.2^a	71.8–81.8
Unknown	60	18.4^b	14.5–22.9

NSS needles and syringes sharing, GP source GP as source of health information, none no injection, SDU service for drug users, SDU source service for drug users as source of health information, Source of information source of health information, HCV screening adequate less than 1 year or absence of injection since the last test, Inadequate current injector with more than 1 year since the lest test, absent no test
^aPrevalence among screened DUs
^bPrevalence among the 327 DUs

ISSN: 1477-7517